Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hallvard Holdaas

Showing results (51-60 of 156) with videos related to

Pageof 16
Sort By:
Clinical Transplantation|July 15, 2009
Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatmentInga Soveri, Sadollah Abedini, Hallvard Holdaas, et al.
Transplantation|November 9, 2007
Clinicians underestimate gastrointestinal symptoms and overestimate quality of life in renal transplant recipients: a multinational survey of nephrologistsHenrik Ekberg, Lauri Kyllönen, Søren Madsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 27, 2002
[Type 2 diabetes and nephropathy--new studies, new treatment strategies?]Ingrid Os, Aud Stenehjem, Aud Høieggen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 23, 2003
[How are living kidney donors doing?]Lars Westlie, Torbjørn Leivestad, Hallvard Holdaas, et al.
Transplantation|February 14, 2007
Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipientsHenrik Ekberg, Lauri Kyllönen, Søren Madsen, et al.
Clinical Transplantation|May 19, 2015
Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients--a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trialKlaus Murbraech, Richard Massey, Liv H Undset, et al.
Clinical Transplantation|November 15, 2006
No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) studyBengt Fellström, Sadollah Abedini, Hallvard Holdaas, et al.
Clinical Transplantation|September 13, 2011
Age, gender, and body mass index are associated with renal function after kidney donationGeir Mjøen, Ole Oyen, Karsten Midtvedt, et al.
Transplantation|June 12, 2012
A cardiovascular risk calculator for renal transplant recipientsInga Soveri, Ingar Holme, Hallvard Holdaas, et al.
BMC Nephrology|August 24, 2018
Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity scoreAmin Ussif, Hege Pihlstrøm, Andreas Pasch, et al.
Pageof 16

Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
Clinical Transplantation|July 15, 2009
Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatmentInga Soveri, Sadollah Abedini, Hallvard Holdaas, et al.
Transplantation|November 9, 2007
Clinicians underestimate gastrointestinal symptoms and overestimate quality of life in renal transplant recipients: a multinational survey of nephrologistsHenrik Ekberg, Lauri Kyllönen, Søren Madsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 27, 2002
[Type 2 diabetes and nephropathy--new studies, new treatment strategies?]Ingrid Os, Aud Stenehjem, Aud Høieggen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 23, 2003
[How are living kidney donors doing?]Lars Westlie, Torbjørn Leivestad, Hallvard Holdaas, et al.
Transplantation|February 14, 2007
Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipientsHenrik Ekberg, Lauri Kyllönen, Søren Madsen, et al.
Clinical Transplantation|May 19, 2015
Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients--a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trialKlaus Murbraech, Richard Massey, Liv H Undset, et al.
Clinical Transplantation|November 15, 2006
No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) studyBengt Fellström, Sadollah Abedini, Hallvard Holdaas, et al.
Clinical Transplantation|September 13, 2011
Age, gender, and body mass index are associated with renal function after kidney donationGeir Mjøen, Ole Oyen, Karsten Midtvedt, et al.
Transplantation|June 12, 2012
A cardiovascular risk calculator for renal transplant recipientsInga Soveri, Ingar Holme, Hallvard Holdaas, et al.
BMC Nephrology|August 24, 2018
Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity scoreAmin Ussif, Hege Pihlstrøm, Andreas Pasch, et al.
Pageof 16